Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Barchas Isaac | Aug 12, 2026 | Sell | $301.06K | 11,048 |
| Director | Barchas Isaac | Aug 11, 2026 | Sell | $1.63M | 62,291 |
| Director | Barchas Isaac | Aug 10, 2026 | Sell | $263.96K | 10,125 |
| Director | Barchas Isaac | Aug 7, 2026 | Sell | $397.36K | 15,248 |
| Director | Barchas Isaac | Aug 6, 2026 | Sell | $543.09K | 20,840 |
| CHIEF BUSINESS OFFICER | Horn Kinney | Aug 4, 2026 | Sell | $2.27M | 90,616 |
| CHIEF BUSINESS OFFICER | Horn Kinney | Jul 7, 2026 | Sell | $27.3K | 1,092 |
| Director | Barchas Isaac | Jul 7, 2026 | Sell | $409.13K | 16,906 |
| Director | Barchas Isaac | Jul 6, 2026 | Sell | $2M | 83,094 |
| Director | Barchas Isaac | Jul 2, 2026 | Sell | $1.69M | 75,665 |
| Chief Medical Officer | Lechleider Robert | Jul 2, 2026 | Sell | $498.57K | 22,714 |
| Director | Barchas Isaac | Jul 2, 2026 | Sell | $567.74K | 24,335 |
| Chief Medical Officer | Lechleider Robert | Jul 2, 2026 | Sell | $369.03K | 16,214 |
| Chief Medical Officer | Lechleider Robert | Jul 2, 2026 | Sell | $376.73K | 16,072 |
| Director | Barchas Isaac | Jun 30, 2026 | Sell | $2.13M | 101,050 |
| Chief Medical Officer | Lechleider Robert | Jun 25, 2026 | Sell | $793.74K | 40,580 |
| Chief Medical Officer | Lechleider Robert | Jun 25, 2026 | Sell | $297.92K | 14,420 |
| CFO | Rosett Max | Jun 15, 2026 | Sell | $1.09M | 60,000 |
| Director | BIENAIME JEAN JACQUES | Jun 5, 2026 | Sell | $9.72K | 500 |
| Director | BIENAIME JEAN JACQUES | Jun 5, 2026 | Sell | $194.1K | 10,000 |
| Director | BIENAIME JEAN JACQUES | Jun 5, 2026 | Buy | $116.88K | 6,000 |
| Director | BIENAIME JEAN JACQUES | Jun 5, 2026 | Buy | $68.11K | 3,500 |
| Director | BIENAIME JEAN JACQUES | Jun 5, 2026 | Buy | $19.27K | 1,000 |
| Director | BIENAIME JEAN JACQUES | May 15, 2026 | Buy | $103.5K | 5,000 |
| Chief Scientific Officer | Higgins Jack | Apr 2, 2026 | Sell | $204.24K | 9,438 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
